Applied BioCode Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 54.05 million compared to TWD 83.86 million a year ago. Net loss was TWD 73.83 million compared to TWD 23.92 million a year ago. Basic loss per share from continuing operations was TWD 0.9 compared to TWD 0.29 a year ago. Diluted loss per share from continuing operations was TWD 0.9 compared to TWD 0.29 a year ago.